Lantheus Holdings Past Earnings Performance
Past criteria checks 1/6
Lantheus Holdings has been growing earnings at an average annual rate of 58.1%, while the Medical Equipment industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 31.4% per year. Lantheus Holdings's return on equity is 15%, and it has net margins of 11%.
Key information
58.14%
Earnings growth rate
58.09%
EPS growth rate
| Medical Equipment Industry Growth | 8.90% |
| Revenue growth rate | 31.35% |
| Return on equity | 14.98% |
| Net Margin | 10.99% |
| Last Earnings Update | 30 Sep 2025 |
Recent past performance updates
Lantheus Holdings' (NASDAQ:LNTH) Conservative Accounting Might Explain Soft Earnings
Aug 16
Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem
Nov 13Recent updates
The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price
Nov 13Positive Sentiment Still Eludes Lantheus Holdings, Inc. (NASDAQ:LNTH) Following 26% Share Price Slump
Sep 05Lantheus Holdings' (NASDAQ:LNTH) Conservative Accounting Might Explain Soft Earnings
Aug 16Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?
Aug 03Returns on Capital Paint A Bright Future For Lantheus Holdings (NASDAQ:LNTH)
Jul 12Lantheus Holdings, Inc.'s (NASDAQ:LNTH) 25% Cheaper Price Remains In Tune With Earnings
May 22Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 22Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry
Mar 07Lacklustre Performance Is Driving Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Low P/E
Feb 13Lantheus Holdings (NASDAQ:LNTH) Seems To Use Debt Rather Sparingly
Jan 26Lantheus Holdings: Powerhouse Potential In 2025
Jan 02If EPS Growth Is Important To You, Lantheus Holdings (NASDAQ:LNTH) Presents An Opportunity
Dec 21Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem
Nov 13Lantheus Holdings: Q3 Results Were Good But Market Overreacted
Nov 08Investors Still Waiting For A Pull Back In Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 03Lantheus: PYLARIFY's Enhanced Prospects Are Welcome, But Don't Get Too Greedy Now
Oct 21Lantheus Holdings (NASDAQ:LNTH) Is Achieving High Returns On Its Capital
Oct 16We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease
Sep 28
PYLARIFY's Strategic Moves Foster Growth In Oncology And Alzheimer's Markets
Expansion into the Alzheimer's diagnostic space and strategic acquisitions suggest diversification and potential for long-term growth in revenue sources.Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)
Aug 12Here's Why Lantheus Holdings (NASDAQ:LNTH) Has Caught The Eye Of Investors
Aug 05Investors Appear Satisfied With Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Prospects As Shares Rocket 49%
Jul 17Lantheus Holdings (NASDAQ:LNTH) Is Investing Its Capital With Increasing Efficiency
Jul 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Jun 24Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus
May 23Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
May 10Lantheus Holdings: Powerful First Quarter
May 05Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital
Apr 12Lantheus Holdings: Undervalued With A Good Outlook
Feb 28Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
Feb 24Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Feb 08Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings
Jan 03Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing
Dec 16A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 28Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Nov 09Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down
Sep 04Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Aug 09Revenue & Expenses Breakdown
How Lantheus Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 25 | 1,526 | 168 | 441 | 165 |
| 30 Jun 25 | 1,521 | 271 | 395 | 141 |
| 31 Mar 25 | 1,537 | 254 | 380 | 156 |
| 31 Dec 24 | 1,534 | 312 | 374 | 168 |
| 30 Sep 24 | 1,497 | 428 | 345 | 150 |
| 30 Jun 24 | 1,438 | 428 | 335 | 140 |
| 31 Mar 24 | 1,366 | 461 | 314 | 95 |
| 31 Dec 23 | 1,296 | 327 | 276 | 62 |
| 30 Sep 23 | 1,206 | 104 | 268 | 318 |
| 30 Jun 23 | 1,125 | 33 | 243 | 316 |
| 31 Mar 23 | 1,027 | -18 | 232 | 314 |
| 31 Dec 22 | 935 | 28 | 234 | 312 |
| 30 Sep 22 | 801 | 107 | 249 | 51 |
| 30 Jun 22 | 664 | 32 | 236 | 49 |
| 31 Mar 22 | 542 | -37 | 237 | 47 |
| 31 Dec 21 | 425 | -71 | 209 | 45 |
| 30 Sep 21 | 390 | -34 | 154 | 44 |
| 30 Jun 21 | 376 | -27 | 145 | 44 |
| 31 Mar 21 | 341 | -8 | 103 | 36 |
| 31 Dec 20 | 339 | -13 | 98 | 30 |
| 30 Sep 20 | 335 | 0 | 100 | 25 |
| 30 Jun 20 | 332 | 12 | 101 | 18 |
| 31 Mar 20 | 352 | 25 | 107 | 19 |
| 31 Dec 19 | 347 | 32 | 103 | 20 |
| 30 Sep 19 | 344 | 35 | 98 | 20 |
| 30 Jun 19 | 347 | 39 | 94 | 20 |
| 31 Mar 19 | 347 | 42 | 93 | 18 |
| 31 Dec 18 | 343 | 41 | 93 | 17 |
| 30 Sep 18 | 338 | 124 | 94 | 16 |
| 30 Jun 18 | 329 | 124 | 92 | 16 |
| 31 Mar 18 | 333 | 127 | 89 | 17 |
| 31 Dec 17 | 331 | 123 | 92 | 18 |
| 30 Sep 17 | 324 | 31 | 84 | 18 |
| 30 Jun 17 | 318 | 27 | 81 | 17 |
| 31 Mar 17 | 307 | 21 | 79 | 15 |
| 31 Dec 16 | 302 | 27 | 75 | 12 |
| 30 Sep 16 | 299 | 26 | 75 | 12 |
| 30 Jun 16 | 300 | 27 | 74 | 11 |
| 31 Mar 16 | 295 | -5 | 79 | 11 |
| 31 Dec 15 | 293 | -15 | 79 | 14 |
| 30 Sep 15 | 299 | -18 | 77 | 16 |
| 30 Jun 15 | 301 | -25 | 79 | 17 |
| 31 Mar 15 | 303 | -2 | 72 | 17 |
| 31 Dec 14 | 302 | -4 | 72 | 14 |
Quality Earnings: LNTH has a large one-off loss of $114.3M impacting its last 12 months of financial results to 30th September, 2025.
Growing Profit Margin: LNTH's current net profit margins (11%) are lower than last year (28.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LNTH's earnings have grown significantly by 58.1% per year over the past 5 years.
Accelerating Growth: LNTH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: LNTH had negative earnings growth (-60.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (13.6%).
Return on Equity
High ROE: LNTH's Return on Equity (15%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 02:54 |
| End of Day Share Price | 2025/11/26 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lantheus Holdings, Inc. is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Yuan Zhi | B. Riley Securities, Inc. |
| Brian Kemp Dolliver | Brookline Capital Markets |